Patient Safety Program Banner

Alerts

MMQC Alerts
MMQC-12-1306 Endo Pharmaceuticals Inc. / Endocet (Oxycodone/Acetaminophen, Usp) / Urgent Drug Recall / DLA 12-160 / Recall To Retail Level Manufacturer has issued a recall on the FOL MATL on 07 MAY 2012. Reason: One bottle from lot was found to contain some Endocet 10/325mg tablets. DISP: Comply with manufacturer distribution instructions if received. Examine stock immediately. Stop dispensing, distributing and quarantine inventory.	MMQC-12-1240 Immediate Message/Ben Vue Laboratories Inc./Polymyxin B for Injection Sterile/Vecuronium Bromide for Injection/FDA Class 1 Recall/DLA 12-130 FDA Class 1 Recall on FOL MATL. Reason: Presence of particulate matter: The potential for glass particulates in these lots of product cannot be eliminated.
MMQC-12-1239 Immediate Message/Glenmark Generics Inc./Norgestimate and Ethinyl Estradiol Tablets USP/FDA Class 1 Recall/DLA 12-061A FDA Class 1 Recall on FOL MATL. Reason: Implemented because of a packaging error, where select blisters were rotated 180 degrees within the card, reversing the weekly tablet orientation and making the lot number and expiry date visible only on the outer pouch.	MMQC-12-1209 Immediate Message/Boehringer Ingelheim, Roxane Laboratories/Ben Venue Laboratories (BVL)/Acetylcysteine Solution/FDA Class 1 Recall/DLA 11-460 SUSPENSE: 4/11/2012 FDA Class 1 Recall on FOL MATL. Reason: Due to the presence of a single glass particle. DISP: Comply with manufacturer distribution instructions if received. Contact any patients that may have received dispensed product and request patients affected lot.